Vimarsana
Biggest News Aggregation in the World

Page 17 - Jack Cox News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jack Cox. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jack Cox Today - Breaking & Trending Today

Biogen Inc.: FDA Accepts Biogen Biologics License Application for BIIB800, A Biosimilar Candidate Referencing ACTEMRA (tocilizumab) - Vimarsana News

Biogen Inc.: FDA Accepts Biogen Biologics License Application for BIIB800, A Biosimilar Candidate Referencing ACTEMRA (tocilizumab)

CAMBRIDGE, Mass., Dec. 09, 2022Inc. (Nasdaq: BIIB) - announced that the U.S. Food and Drug Administration (FDA) has accepted for review the abbreviated Biologics License Application (aBLA) for BIIB800

European Medicines Agency Accepts Tofersen Marketing Authorization Application to Treat Rare, Genetic Form of ALS - Vimarsana News

European Medicines Agency Accepts Tofersen Marketing Authorization Application to Treat Rare, Genetic Form of ALS

SOD1-ALS is a rare, genetic form of ALS,1 comprising approximately 2% of people with ALS2If approved, tofersen would be the first treatment to target a genetic cause of ALS CAMBRIDGE, Mass., Dec. ... | December 5, 2022

Jailed Blackwood drug dealer told 'it's a wicked trade' - Vimarsana News

Jailed Blackwood drug dealer told 'it's a wicked trade'

A MAN who offered to sell crack cocaine was told by a judge he was still a drug dealer who was caught up in a “wicked trade”.

Biogen Names Christopher Viehbacher President and Chief - Vimarsana News

Biogen Names Christopher Viehbacher President and Chief

Distinguished Industry Leader Brings Extensive International Experience in Large Pharmaceutical and Entrepreneurial Biotech Companies...

Biogen Inc.: Biogen Names Christopher Viehbacher President and Chief Executive Officer - Vimarsana News

Biogen Inc.: Biogen Names Christopher Viehbacher President and Chief Executive Officer

Distinguished Industry Leader Brings Extensive International Experience in Large Pharmaceutical and Entrepreneurial Biotech CompaniesCAMBRIDGE, Mass., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (NASDAQ: